Photo

Photo detail

Stories this photo appears in:

ChromaDex Product Gets Aussie OK

ChromaDex Corp. said health regulatory body the Australian Therapeutic Goods Administration approved its nicotinamide riboside chloride “for use in listed complementary medicines” with “market exclusivity” for two years.

Tease photo